|
C1ORF128 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.440650E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.818090E-04 |
| Normal-vs-Stage2 |
3.088600E-01 |
| Normal-vs-Stage3 |
6.941200E-03 |
| Normal-vs-Stage4 |
2.784900E-03 |
| Stage1-vs-Stage2 |
2.109800E-01 |
| Stage1-vs-Stage3 |
7.049400E-01 |
| Stage1-vs-Stage4 |
5.782800E-01 |
| Stage2-vs-Stage3 |
3.741000E-01 |
| Stage2-vs-Stage4 |
1.599180E-01 |
| Stage3-vs-Stage4 |
4.328200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.1886000000031E-05 |
| Normal-vs-AfricanAmerican |
2.115600E-01 |
| Normal-vs-Asian |
9.673800E-02 |
| Caucasian-vs-AfricanAmerican |
7.146800E-01 |
| Caucasian-vs-Asian |
1.764990E-01 |
| AfricanAmerican-vs-Asian |
7.296600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.514490E-02 |
| Normal-vs-Female |
1.002090E-04 |
| Male-vs-Female |
3.328000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.14289999999062E-05 |
| Normal-vs-Age(41-60Yrs) |
5.225800E-02 |
| Normal-vs-Age(61-80Yrs) |
8.007300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.216600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.463600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.093400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.105400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.393560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.161600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.334600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.235500E-03 |
| Classical-VS-Follicular |
2.847800E-01 |
| Classical-VS-Other |
7.901200E-01 |
| Classical-VS-Normal |
2.021600E-03 |
| Tall-VS-Follicular |
2.799500E-03 |
| Tall-VS-Other |
4.981800E-01 |
| Tall-VS-Normal |
2.2114000000073E-06 |
| Follicular-VS-Other |
5.823000E-01 |
| Follicular-VS-Normal |
2.420000E-01 |
| Other-VS-Normal |
3.161600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.810000E-02 |
| Normal-vs-N1 |
3.55920000139065E-08 |
| N0-vs-N1 |
3.75120000000173E-05 |
|
|
